drugset / Trial / NCT06441643
Next Generation Rocklatan
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Timeline
- Start
- 2024-09-04
- Primary completion
- 2025-11-14
- Completion
- 2025-11-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AR-17043 | Unknown | — | Other |
| Comparator | Latanoprost | Small molecule | 0.005 % | Other |
| Comparator | Netarsudil | Small molecule | 0.02 % | Other |